Status:
COMPLETED
A Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD1446 Administered for 4 Weeks in Elderly Healthy Volunteers
Lead Sponsor:
AstraZeneca
Conditions:
Healthy
Eligibility:
All Genders
65-85 years
Phase:
PHASE1
Brief Summary
This study is designed to evaluate the safety, tolerability and pharmacokinetics (PK) of two doses of AZD1446 or placebo in subjects when given for 4 weeks.
Eligibility Criteria
Inclusion
- Male or non-fertile female, elderly Subjects, aged ≥65 to ≤85
- Body mass index (BMI) between 18 and 30 kg/m2
- Clinically normal findings on physical examination
Exclusion
- History of any clinically significant disease or disorder
- History of severe allergy/hypersensitivity reactions including severe food allergy as judged by the investigator.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00997308
Start Date
October 1 2009
End Date
December 1 2009
Last Update
January 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research
Lund, Sweden